Back to Search

JOHN FETTING, M.D.

M.D.

Medical Oncology Physician

NPI: 1013947126Individual

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

D18320(MD)

Research & Publications (12)

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.
PMID 19564528·J Clin Oncol·2009
4-observational
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
PMID 19332718·J Clin Oncol·2009
8-other
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.
PMID 18381931·Clin Cancer Res·2008
4-observational
Pulling the trigger.
PMID 15337815·J Clin Oncol·2004
8-other
Opposing inputs by Hedgehog and Brinker define a stripe of hairy expression in the Drosophila leg imaginal disc.
PMID 15128656·Development·2004
7-preclinical
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.
PMID 15018740·Hum Gene Ther·2004
7-preclinical
A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer.
PMID 14676116·Clin Cancer Res·2003
3-trial
Can you cure him, for the baby's sake?
PMID 14581431·J Clin Oncol·2003
8-other
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
PMID 12840088·N Engl J Med·2003
3-trial
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer.
PMID 12452452·Breast Cancer Res Treat·2002
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
10753 FALLS RD
LUTHERVILLE, MD 21093

Quick Facts

NPI
1013947126
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
12

Are you this provider?

Claim Your Profile